SEQIRUS USA INC - FY26 B1 SEQIRUS USA VACCINES INMATES JAN 26 FLU VACCINES INMATES AND DETAINEES OVER 65
Key Details
Description
FY26 B1 SEQIRUS USA VACCINES INMATES JAN 26 FLU VACCINES INMATES AND DETAINEES OVER 65
Context & Analysis
On Feb 20, 2026, Department of Justice obligated $699.96 to SEQIRUS USA INC for fy26 b1 seqirus usa vaccines inmates jan 26 flu vaccines inmates and detainees over 65. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in ATLANTA, GA. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
MCKESSON CORPORATION
$10.0M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
Stay Updated
Get notified about new opportunities matching your interests.